Agilent Technologies, a global leader in life sciences, diagnostics, and applied chemical markets,  announced the inauguration of its state-of-the-art Agilent Biopharma Experience Centre in Hyderabad. This strategic investment underscores Agilent’s unwavering commitment to supporting India’s biopharmaceutical innovation and talent development.

The facility was formally inaugurated by Shri D. Sridhar Babu, Hon’ble Minister for IT, Electronics, Communications & Industries, Government of Telangana, in the presence of Mr. Padraig McDonnell, President and CEO of Agilent Technologies.

Strategically located in the heart of India’s life sciences capital, the new centre aims to foster collaboration and accelerate the development of life-saving therapies by providing:

• Advanced analytical instrumentation

• Regulatory-ready and compliant workflows

• End-to-end expertise across chromatography, mass spectrometry, cell analysis, and lab informatics

• Hands-on training and knowledge exchange for scientists, researchers, and industry partners

“India is a strategic growth market for Agilent, and Hyderabad is at the forefront of biopharma innovation,” said Padraig McDonnell, President and CEO, Agilent Technologies. “This centre represents our long-term vision to enable innovation, support the government’s ‘Make in India’ initiative, and strengthen the country’s position as a global hub for next-generation drug development.”

The Agilent Biopharma Experience Centre is envisioned as a platform for co-creation—bringing together academia, industry, and government stakeholders to advance precision science and improve access to innovative healthcare solutions.

With this initiative, Agilent continues to play a pivotal role in nurturing India's scientific talent, accelerating regulatory-ready drug development, and driving operational excellence across the biopharmaceutical value chain.